Heron Therapeutics

Heron lays off 25% of employees and renegotiates vendor contracts to save money
Fierce Biotech
Tue, 07/25/23 - 10:17 am
Heron Therapeutics
layoffs
Heron scores FDA go-ahead for Aponvie, an IV alternative to pills for postoperative nausea
Fierce Pharma
Tue, 09/20/22 - 10:05 am
Heron Therapeutics
post-operative nausea and vomiting
Aponvie
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
layoffs
hirings
Astellas
Pfizer
Eikon Therapeutics
Bayer
Avadel Pharma
Heron Therapeutics
Adverum Biotechnologies
Biogen
Eisai
X4 Pharmaceuticals
Assembly Biosciences
Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint
Endpoints
Thu, 06/30/22 - 12:07 pm
Heron Therapeutics
R&D
layoffs
restructuring
Heron, on third attempt, secures FDA approval for non-opioid painkiller
BioPharma Dive
Thu, 05/13/21 - 11:04 am
Heron Therapeutics
FDA
post-operative pain
non-opioid pain treatments
Zynrelef
Go or no go? Apellis and Heron head for the finish line
EP Vantage
Fri, 04/30/21 - 10:30 am
Apellis
anemia
pegcetacoplan
Heron Therapeutics
HTX-011
FDA
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Motley Fool
Wed, 11/11/20 - 11:01 am
Biogen
M&A
Aurinia
Cassava Sciences
Heron Therapeutics
Heron's wings clipped again with another FDA rejection for opioid alternative
Fierce Biotech
Mon, 06/29/20 - 10:02 am
Heron Therapeutics
complete response letter
FDA
non-opioid pain treatments
HTX-011
Biotech's Most Volatile Binary Events for Q1
Motley Fool
Fri, 01/3/20 - 10:24 am
FDA
Esperion Therapeutics
Karyopharm
TG Therapeutics
Heron Therapeutics
Manufacturing issues hobble Heron’s quest to market its long-acting non-opioid painkiller
Endpoints
Thu, 05/2/19 - 11:05 am
Heron Therapeutics
Pacira Pharmaceuticals
FDA
post-surgical pain
HTX-011
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Go or no go? Abbvie, Glaxo and Heron await FDA verdicts
EP Vantage
Thu, 03/28/19 - 10:18 am
FDA
AbbVie
Heron Therapeutics
HTX-011
GSK
dolutegravir/lamivudine
risankizumab
Gimoti
Evoke Pharma
Heron's non-opioid HTX-011 gets Priority Review
BioCentury
Wed, 01/2/19 - 06:49 pm
priority review
Heron Therapeutics
HTX-011
post-operative pain
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
CP Wire
Thu, 06/21/18 - 09:44 am
Heron Therapeutics
HTX-011
pain management
post-operative pain
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Thu, 06/21/18 - 09:17 am
Heron Therapeutics
HTX-011
pain management
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
Sun, 03/25/18 - 11:29 am
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
Mon, 11/13/17 - 09:22 am
earnings
Synergy Pharmaceuticals
Omeros
BioDelivery Sciences
Heron Therapeutics
Dynavax
Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti
Fierce Pharma
Fri, 11/10/17 - 09:39 am
Heron Therapeutics
Merck
FDA
Emend
Cinvanti
chemotherapy-induced nausea and vomiting
Heron Therapeutics Shows Potential In The Chemotherapy-Induced-Nausea Market
Seeking Alpha
Mon, 07/10/17 - 11:24 pm
Heron Therapeutics
chemotherapy-induced nausea and vomiting
Cinvanti
Recent FDA Approvals - Aug 15 2016
CP Wire
Mon, 08/15/16 - 03:50 pm
Aurobindo
Merck
FDA
drug approvals
Sun Pharma
Santarus
Keytruda
Boston Scientific
devices
Heron Therapeutics

Pages